1. Home
  2. CARA vs FEDU Comparison

CARA vs FEDU Comparison

Compare CARA & FEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARA
    SELLHOLDBUYas of 20 hours ago
  • FEDU
    SELLHOLDBUYas of 20 hours ago
  • Stock Information
  • Founded
  • CARA 2004
  • FEDU 2007
  • Country
  • CARA United States
  • FEDU China
  • Employees
  • CARA N/A
  • FEDU N/A
  • Industry
  • CARA Biotechnology: Pharmaceutical Preparations
  • FEDU
  • Sector
  • CARA Health Care
  • FEDU
  • Exchange
  • CARA Nasdaq
  • FEDU NYSE
  • Market Cap
  • CARA 23.2M
  • FEDU 20.0M
  • IPO Year
  • CARA 2014
  • FEDU 2017
  • Fundamental
  • Price
  • CARA $4.80
  • FEDU $8.91
  • Analyst Decision
  • CARA Hold
  • FEDU
  • Analyst Count
  • CARA 3
  • FEDU 0
  • Target Price
  • CARA $12.00
  • FEDU N/A
  • AVG Volume (30 Days)
  • CARA 12.2K
  • FEDU 5.0K
  • Earning Date
  • CARA 05-12-2025
  • FEDU 12-20-2024
  • Dividend Yield
  • CARA N/A
  • FEDU 26.79%
  • EPS Growth
  • CARA N/A
  • FEDU N/A
  • EPS
  • CARA N/A
  • FEDU 0.12
  • Revenue
  • CARA $7,137,000.00
  • FEDU $27,971,139.00
  • Revenue This Year
  • CARA N/A
  • FEDU N/A
  • Revenue Next Year
  • CARA N/A
  • FEDU N/A
  • P/E Ratio
  • CARA N/A
  • FEDU $77.44
  • Revenue Growth
  • CARA N/A
  • FEDU 141.14
  • 52 Week Low
  • CARA $2.71
  • FEDU $7.41
  • 52 Week High
  • CARA $10.74
  • FEDU $22.70
  • Technical
  • Relative Strength Index (RSI)
  • CARA 42.00
  • FEDU 40.57
  • Support Level
  • CARA $4.88
  • FEDU $9.27
  • Resistance Level
  • CARA $5.15
  • FEDU $10.18
  • Average True Range (ATR)
  • CARA 0.27
  • FEDU 0.67
  • MACD
  • CARA -0.06
  • FEDU 0.02
  • Stochastic Oscillator
  • CARA 6.90
  • FEDU 16.52

Stock Price Comparison Chart: CARA vs FEDU

CARA
FEDU
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April024681012141618202224262830CARA VS FEDU

About CARA Cara Therapeutics Inc.

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)

Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use